Wright AK, Carr MJ, Kontopantelis E, et al
The med, under the brand name Scenesse, is used to treat a rare genetic disorder erythropoietic protoporphyria (EPP) where people experience extreme light sensitivity, says Naiem T
While semaglutide itself does not appear to directly promote kidney stone formation through its mechanism of action, patients experiencing significant gastrointestinal symptoms or rapid weight loss may face increased risk if adequate hydration is not maintained
That constancy is the trade-off: MK-677 eliminates natural GH troughs, which normally allow IGF-1 receptor resensitization and metabolic recovery
Further studies are recommended to explore additional benefits, meanwhile it is prudent to advise L-carnitine supplementation for such patients
Chollet, F